BUSINESS AREA
INFORMATION TECHNOLOGY (IT) & DIGITAL SYSTEMS
When legacy systems limit progress, we help IT lead transformation.
Pharmaceutical and biotech organizations are under pressure to modernize legacy systems while meeting strict regulatory and security standards. Disconnected platforms and outdated validation slow transformation and raise compliance risk.
Osprey Life Sciences helps pharmaceutical IT and Digital teams implement connected, compliant, and business-driven solutions. With decades of GxP experience, we modernize digital ecosystems – linking ERP, QMS, LIMS, RIM, CRM, and MES for better visibility and efficiency. Our consultants combine IT, quality, and program management expertise to ensure systems are regulatory-ready, technically sound, and built to scale securely.
Discover the impact we’ve made with our life sciences partners
Powering Enterprise-Scale Research Through a Custom Clinical Trial Platform
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Transforming Competitive Insights into a Scalable, Governed Enterprise Capability
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Strengthening Identity Governance Through a Compliant SailPoint Implementation
Gearing up for a pivotal BLA submission, sought to revolutionize its document management and regulatory transparency.
Industry trends, expert perspectives, and innovative solutions
Why Technology Buyers Struggle with Large Consulting Firms and Prefer High-Value Smaller Partners
Technology leaders face constant pressure to deliver solutions that are innovative, reliable, and tailored to the needs of the business. When seeking external expertise, many organizations instinctively turn to large consulting firms based on name recognition, global...
Top 5 Ways Life Sciences Companies Can Prepare for an FDA Inspection
As FDA resources tighten and regulatory expectations evolve, inspection readiness has never been more critical. Life sciences companies – whether in pharmaceuticals, biotech, or medical devices – must take a proactive and structured approach to ensure they are...
FDA Inspection Readiness – Is Your Company Truly Prepared?
Introduction In an environment where the FDA is experiencing resource limitations, life sciences companies face heightened scrutiny during regulatory inspections. Achieving consistent inspection readiness has never been more critical. This article discusses...